or Try an Advanced Search...

    Biomarkers Stocks List

    Symbol Grade Name % Change
    MYGN F Myriad Genetics, Inc. 0.36
    TTOO F T2 Biosystems, Inc. -1.93
    CNTG F Centogene N.V. 0.00
    ANRO F Alto Neuroscience, Inc. -7.49
    POAI F Predictive Oncology Inc. 5.58
    LIXT F Lixte Biotechnology Holdings, Inc. 2.01
    ACON F Aclarion, Inc. 1.42
    QTRX F Quanterix Corporation 6.35
    CGEN F Compugen Ltd. 1.40
    IDYA F IDEAYA Biosciences, Inc. 4.15
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Health Information Services Medical Devices Medical Instruments & Supplies
    Related Stock Lists: Medicine Biotechnology Autoimmunity Biology Biopharmaceutical Clinical Medicine Immunology Allergy Antibody Autoimmune Disorders Cancer Chemical Pathology Immune Disorders Infectious Diseases Life Sciences Monoclonal Antibody Neuroscience Recruitment Abnormal Psychology Allergic Conjunctivitis

    Related ETFs - A few ETFs which own one or more of the above listed Biomarkers stocks.

    Symbol Grade Name Weight
    EIRL D iShares MSCI Ireland Capped ETF 16.38
    PCIG F Polen Capital International Growth ETF 10.24
    BBH D Market Vectors Biotech ETF 5.66
    GNOM F Global X Genomics & Biotechnology ETF 3.83
    LGHT D Langar Global HealthTech ETF 3.53
    View all Biomarkers ETFs...
    Compare ETFs
    Compare EIRL to GNOM Compare EIRL to PCIG Compare GNOM to LGHT

        Biomarkers Stocks Recent News

        Date Stock Title
        Nov 21 ACON Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash
        Nov 20 MYGN Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina’s Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2
        Nov 19 MYGN Myriad Genetics Announces Prequel® Prenatal Screening Can Now be Performed Eight Weeks into Pregnancy
        Nov 19 MYGN Myriad Genetics price target lowered to $21 from $32 at Morgan Stanley
        Nov 18 IDYA IDEAYA Biosciences Appoints Stu Dorman as Chief Commercial Officer
        Nov 15 IDYA Jim Cramer Says This Tobacco Stock Is 'Undervalued' But He's Not Recommending It
        Nov 15 POAI Predictive Oncology Third Quarter 2024 Earnings: Misses Expectations
        Nov 15 CGEN Compugen Ltd. (NASDAQ:CGEN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
        Nov 14 TTOO T2 Biosystems, Inc. (TTOO) Q3 2024 Earnings Call Transcript
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Health Information Services Medical Devices Medical Instruments & Supplies
        Related Stock Lists: Medicine Biotechnology Autoimmunity Biology Biopharmaceutical Clinical Medicine Immunology Allergy Antibody Autoimmune Disorders Cancer Chemical Pathology Immune Disorders Infectious Diseases Life Sciences Monoclonal Antibody Neuroscience Recruitment Abnormal Psychology Allergic Conjunctivitis
        Biomarkers

        A biomarker, or biological marker is a measurable indicator of some biological state or condition. Biomarkers are often measured and evaluated to examine normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. Biomarkers are used in many scientific fields.

        More about Biomarkers
        Browse All Tags